Ignite Creation Date:
2025-12-24 @ 4:56 PM
Ignite Modification Date:
2025-12-30 @ 7:30 AM
Study NCT ID:
NCT00098150
Status:
COMPLETED
Last Update Posted:
2006-08-31
First Post:
2004-12-03
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Follow-Up Study of Patients Previously Treated With Pimecrolimus Tablets for Atopic Dermatitis
Sponsor:
Organization:
Raw JSON
{'hasResults': False, 'derivedSection': {'miscInfoModule': {'versionHolder': '2025-12-24'}, 'conditionBrowseModule': {'meshes': [{'id': 'D003876', 'term': 'Dermatitis, Atopic'}], 'ancestors': [{'id': 'D012873', 'term': 'Skin Diseases, Genetic'}, {'id': 'D030342', 'term': 'Genetic Diseases, Inborn'}, {'id': 'D009358', 'term': 'Congenital, Hereditary, and Neonatal Diseases and Abnormalities'}, {'id': 'D003872', 'term': 'Dermatitis'}, {'id': 'D012871', 'term': 'Skin Diseases'}, {'id': 'D017437', 'term': 'Skin and Connective Tissue Diseases'}, {'id': 'D017443', 'term': 'Skin Diseases, Eczematous'}, {'id': 'D006969', 'term': 'Hypersensitivity, Immediate'}, {'id': 'D006967', 'term': 'Hypersensitivity'}, {'id': 'D007154', 'term': 'Immune System Diseases'}]}}, 'protocolSection': {'designModule': {'studyType': 'OBSERVATIONAL', 'designInfo': {'timePerspective': 'RETROSPECTIVE', 'observationalModel': 'DEFINED_POPULATION'}, 'enrollmentInfo': {'count': 66}}, 'statusModule': {'overallStatus': 'COMPLETED', 'startDateStruct': {'date': '2004-07'}, 'statusVerifiedDate': '2006-08', 'lastUpdateSubmitDate': '2006-08-29', 'studyFirstSubmitDate': '2004-12-03', 'studyFirstSubmitQcDate': '2004-12-03', 'lastUpdatePostDateStruct': {'date': '2006-08-31', 'type': 'ESTIMATED'}, 'studyFirstPostDateStruct': {'date': '2004-12-06', 'type': 'ESTIMATED'}}, 'conditionsModule': {'keywords': ['Safety, atopic dermatitis, adverse event, SAE, extension'], 'conditions': ['Atopic Dermatitis']}, 'descriptionModule': {'briefSummary': 'This extension study is being conducted to collect post-treatment safety information on patients who previously participated in the core clinical trial.'}, 'eligibilityModule': {'sex': 'ALL', 'stdAges': ['ADULT', 'OLDER_ADULT'], 'minimumAge': '18 Years', 'healthyVolunteers': False, 'eligibilityCriteria': 'Inclusion Criteria:\n\n* Consenting patients who participated in the core clinical trial'}, 'identificationModule': {'nctId': 'NCT00098150', 'briefTitle': 'Follow-Up Study of Patients Previously Treated With Pimecrolimus Tablets for Atopic Dermatitis', 'organization': {'class': 'INDUSTRY', 'fullName': 'Novartis'}, 'officialTitle': 'A Follow-Up Study of Patients Previously Treated in a Core Study With Pimecrolimus Tablets for Atopic Dermatitis', 'orgStudyIdInfo': {'id': 'Ext 1 to ASM981C202'}}, 'sponsorCollaboratorsModule': {'leadSponsor': {'name': 'Novartis', 'class': 'INDUSTRY'}}}}